Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccines.

Source:http://linkedlifedata.com/resource/pubmed/id/7533967

Download in:

View as

General Info

PMID
7533967